HOME >> MEDICINE >> NEWS
International breast cancer prevention study launches in the United States and Canada

Boston-March 30, 2005 Today, a new clinical trial evaluating a novel approach to breast cancer prevention launched in the United States and Canada. Called the ExCel research study, this is the first North American clinical trial to evaluate the role of an aromatase inhibitor in the prevention of breast cancer.

Coordinated by the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG), the ExCel research study will examine the potential benefit of exemestane and its ability to prevent breast cancer in women who are at increased risk for the disease. Exemestane part of a class of drugs called aromatase inhibitors suppresses estrogen production, a key component in the development of some types of breast cancer. Exemestane could provide women with an alternative option to tamoxifen, the only drug FDA approved for prevention of breast cancer.

"Breast cancer is a major public health issue every 30 seconds somewhere in the world a woman is diagnosed with this disease," says Dr. Paul Goss, the ExCel research study chair.

"Thousands of women have already beat breast cancer thanks to recent research on aromatase inhibitors. As a result, we think this could be an effective approach to preventing it from developing in the first place."

The ExCel research study will follow more than 4,500 postmenopausal women from the U.S., Canada and Spain over a five year period. To be eligible, women must be 35 years of age or older and have an increased risk of developing breast cancer. Risk factors can include a woman's age, her family history of breast cancer, her age at first menstrual period and her age at first live birth.

Initial results of the trial could be available within four years and study investigators hope to see as much as a two-thirds reduction in the incidence of breast cancer among women in the treatment group.

Aromatase inhibitors are currently being used to treat breast cancer in wo
'"/>

Contact: Samantha Kaplan
samantha.kaplan@edelman.com
312-297-7439
Edelman Public Relations
30-Mar-2005


Page: 1 2 3 4

Related medicine news :

1. National Academies advisory: May 2 Symposium on International Science Policy
2. Awards & fellowships at the International & American Association for Dental Research General Session
3. Lectures, keynoters, symposia highlight International Dental Research meeting
4. Advances in Uterine Leiomyoma Research: 2nd NIH International Congress
5. International gathering of experts to share retinoblastoma breakthroughs
6. International trial of two microbicides begins
7. International gathering at UH examines top computer code
8. International trial finds benefits of breast MRI in women at high risk
9. International study provides culture-by-culture clues to family violence and abuse
10. St. Jude scientist wins International Society of Experimental Hematology award
11. International MRC trial finds a routine treatment for head injury may do more harm than good

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/19/2019)... ... April 19, 2019 , ... The Patient Advocacy Community of ... Health Network-CVPH, Plattsburgh, NY with the 2019 Ruth Ravich Patient Advocacy Award in ... fellow patient advocates. Doyle was honored with the award at The Beryl Institute’s ...
(Date:4/18/2019)... ... April 18, 2019 , ... Swiss Pet company PerAnimal launches ... support the bond between human and animal while improving the overall wellness of pet ... specialists with decades of experience. They are made by hand from organic Swiss herbal ...
(Date:4/18/2019)... ... April 18, 2019 , ... Dr. Matt Nejad is a ... full menu of cosmetic and general dental care services. Dr. Nejad is most ... relies on minimally-invasive techniques in restorative dentistry. Biomimetic dentistry uses a more holistic ...
(Date:4/18/2019)... , ... April 18, 2019 , ... ... the best provider for their care. Through the rise of online review sites ... level of interaction and transparency when making important purchasing decisions online. In order ...
(Date:4/17/2019)... ... April 17, 2019 , ... Historically, patients ... reluctance appears to be changing. Whether because of demographic or generational changes, patients ... healthcare providers advice. , In the past, efforts to publish performance data about ...
Breaking Medicine News(10 mins):
(Date:4/17/2019)... ... , ... Knight Security’s patented KnightSentry technology achieved another level ... Security Today magazine in its annual The Govies Government Security Awards competition. This ... recognizing outstanding government security products. , Knight’s innovative KnightSentry platform continuously scans the ...
(Date:4/17/2019)... ... 2019 , ... The Job Research Foundation has announced the recipients ... of and treatments for Job Syndrome. , The Foundation awarded three two-year grants ... globe in three countries, and on three continents. The recipients are: , ...
(Date:4/17/2019)... ... April 17, 2019 , ... Clinical trials of new cancer ... colon cancer and so on. With advances in medical oncology and genomic characterization of ... in multiple tumor types by conducting “basket trials.” This ability has created a paradigm ...
Breaking Medicine Technology:
Cached News: